• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌患者尿液中的TMPRSS2:ERG融合转录本与较差的预后相关。

TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis.

作者信息

Rostad Kari, Hellwinkel Olaf J C, Haukaas Svein A, Halvorsen Ole J, Øyan Anne M, Haese Alexander, Budäus Lars, Albrecht Heiko, Akslen Lars A, Schlomm Thorsten, Kalland Karl-Henning

机构信息

The Gade Institute, University of Bergen, Bergen, Norway.

出版信息

APMIS. 2009 Aug;117(8):575-82. doi: 10.1111/j.1600-0463.2009.02517.x.

DOI:10.1111/j.1600-0463.2009.02517.x
PMID:19664128
Abstract

The transcription factor ERG is highly upregulated in the majority of prostate cancers due to chromosomal fusion of the androgen responsive promoter of TMPRSS2 to the ERG reading frame. Our aim was to identify this gene fusion in urine samples from prostate cancer patients prior to radical treatment and to compare fusion status with clinicopathological variables. Urine fractions from 55 patients (with and without prior prostatic massage) were analyzed for the presence of TMPRSS2:ERG isoforms using real-time qPCR. Sixty-nine percent of urine samples following prostatic massage were positive for TMPRSS2:ERG isoforms a or b, five out of which were positive for both, vs 24% of samples obtained without prior massage. Isoform a seems to be most prevalent and some patients may be positive for more than one fusion variant, reflecting the multifocality of prostate cancer. Prostatic massage prior to sampling, analysis of pelleted urine material and detection of cDNA provided the highest sensitivity. Positive statistical correlations were identified between TMPRSS2:ERG fusion and high s-PSA, pathological stage and Gleason score. Our findings contribute to the increasing elucidation of the role of TMPRSS2:ERG in the development of prostate cancer.

摘要

由于TMPRSS2的雄激素反应性启动子与ERG读码框发生染色体融合,转录因子ERG在大多数前列腺癌中高度上调。我们的目的是在根治性治疗前从前列腺癌患者的尿液样本中鉴定这种基因融合,并将融合状态与临床病理变量进行比较。使用实时定量PCR分析了55例患者(有或没有前列腺按摩史)的尿液成分中TMPRSS2:ERG异构体的存在情况。前列腺按摩后的尿液样本中,69%的样本TMPRSS2:ERG异构体a或b呈阳性,其中5例两种异构体均为阳性,而未进行前列腺按摩的样本中这一比例为24%。异构体a似乎最为常见,一些患者可能不止一种融合变体呈阳性,这反映了前列腺癌的多灶性。采样前进行前列腺按摩、分析沉淀的尿液物质以及检测cDNA可提供最高的灵敏度。TMPRSS2:ERG融合与高血清前列腺特异抗原、病理分期和 Gleason评分之间存在正相关。我们的研究结果有助于进一步阐明TMPRSS2:ERG在前列腺癌发生发展中的作用。

相似文献

1
TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis.前列腺癌患者尿液中的TMPRSS2:ERG融合转录本与较差的预后相关。
APMIS. 2009 Aug;117(8):575-82. doi: 10.1111/j.1600-0463.2009.02517.x.
2
Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer.检测尿沉渣中的TMPRSS2-ERG融合转录本和前列腺癌抗原3可能会改善前列腺癌的诊断。
Clin Cancer Res. 2007 Sep 1;13(17):5103-8. doi: 10.1158/1078-0432.CCR-07-0700.
3
Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer.前列腺特异性 TMPRSS2(exon 0)-ERG 融合转录物的过表达与前列腺癌的良好预后相关。
Clin Cancer Res. 2009 Oct 15;15(20):6398-403. doi: 10.1158/1078-0432.CCR-09-1176. Epub 2009 Oct 13.
4
Clinical implications of TMPRSS2-ERG gene fusion expression in patients with prostate cancer treated with radical prostatectomy.在接受根治性前列腺切除术治疗的前列腺癌患者中,TMPRSS2-ERG 基因融合表达的临床意义。
J Urol. 2010 May;183(5):2054-61. doi: 10.1016/j.juro.2009.12.096. Epub 2010 Mar 19.
5
[Frequency and transcript variant analysis of gene fusions between TMPRSS2 and ETS transcription factor genes in prostate cancer].[前列腺癌中TMPRSS2与ETS转录因子基因之间基因融合的频率及转录本变异分析]
Zhonghua Yi Xue Za Zhi. 2008 Mar 11;88(10):669-73.
6
Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer.50例前列腺癌中TMPRSS2-ERG和TMPRSS2-ETV1基因融合的分子遗传学分析。
Oncol Rep. 2007 May;17(5):1033-6.
7
Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer.家族性前列腺癌中TMPRSS2-ERG融合的全基因组连锁分析。
Cancer Res. 2009 Jan 15;69(2):640-6. doi: 10.1158/0008-5472.CAN-08-2008.
8
Association of SPINK1 expression and TMPRSS2:ERG fusion with prognosis in endocrine-treated prostate cancer.SPINK1 表达和 TMPRSS2:ERG 融合与内分泌治疗前列腺癌预后的关系。
Clin Cancer Res. 2010 May 15;16(10):2845-51. doi: 10.1158/1078-0432.CCR-09-2505. Epub 2010 May 4.
9
Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer.变异型TMPRSS2/ERG融合信使核糖核酸的表达与侵袭性前列腺癌相关。
Cancer Res. 2006 Sep 1;66(17):8347-51. doi: 10.1158/0008-5472.CAN-06-1966.
10
Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.前列腺癌男性尿液中TMPRSS2:ERG融合转录本的无创检测
Neoplasia. 2006 Oct;8(10):885-8. doi: 10.1593/neo.06625.

引用本文的文献

1
A cross-sectional study of ERG expression and the relationship with clinicopathological features of Prostate cancer in Southwestern Uganda.乌干达西南部前列腺癌中 ERG 表达的横断面研究及其与临床病理特征的关系。
Diagn Pathol. 2024 May 10;19(1):67. doi: 10.1186/s13000-024-01494-1.
2
Characterization of stage-specific tumor progression in TMPRSS2-ERG (fusion)-driven and non-fusion-driven prostate cancer in GEM models.在 GEM 模型中,TMPRSS2-ERG(融合)驱动和非融合驱动的前列腺癌中特定阶段肿瘤进展的特征。
Mol Carcinog. 2022 Jul;61(7):717-734. doi: 10.1002/mc.23413. Epub 2022 Apr 22.
3
Past, Current, and Future Strategies to Target ERG Fusion-Positive Prostate Cancer.
靶向ERG融合阳性前列腺癌的过去、当前及未来策略
Cancers (Basel). 2022 Feb 22;14(5):1118. doi: 10.3390/cancers14051118.
4
Liquid Biopsy to Detect DNA/RNA Based Markers of Small DNA Oncogenic Viruses for Prostate Cancer Diagnosis, Prognosis, and Prediction.液体活检用于检测基于DNA/RNA的小DNA致癌病毒标志物以进行前列腺癌的诊断、预后评估和预测。
Front Oncol. 2020 Jul 8;10:778. doi: 10.3389/fonc.2020.00778. eCollection 2020.
5
NMR-based metabolomics studies of human prostate cancer tissue.基于 NMR 的人前列腺癌组织代谢组学研究。
Metabolomics. 2018 Jun 18;14(7):88. doi: 10.1007/s11306-018-1384-2.
6
Status of - fusion in prostate cancer patients from India: correlation with clinico-pathological details and Met160Val polymorphism.印度前列腺癌患者中-融合的状态:与临床病理细节及Met160Val多态性的相关性
Prostate Int. 2018 Dec;6(4):145-150. doi: 10.1016/j.prnil.2018.03.004. Epub 2018 Mar 26.
7
Predictive significance of - fusion in prostate cancer: a meta-analysis.-融合在前列腺癌中的预测意义:一项荟萃分析。
Cancer Cell Int. 2018 Nov 12;18:177. doi: 10.1186/s12935-018-0672-2. eCollection 2018.
8
TMPRSS2:ERG gene aberrations may provide insight into pT stage in prostate cancer.TMPRSS2:ERG基因畸变可能为前列腺癌的pT分期提供见解。
BMC Urol. 2016 Jul 4;16(1):35. doi: 10.1186/s12894-016-0160-8.
9
The tumor suppressive miR-200b subfamily is an ERG target gene in human prostate tumors.肿瘤抑制性miR-200b亚家族是人类前列腺肿瘤中的一个ERG靶基因。
Oncotarget. 2016 Jun 21;7(25):37993-38003. doi: 10.18632/oncotarget.9366.
10
Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate Cancer.尿液外泌体用于前列腺癌基因表达和突变的无创评估。
PLoS One. 2016 May 4;11(5):e0154507. doi: 10.1371/journal.pone.0154507. eCollection 2016.